Our Head of Professional and Enterprise Disputes Malenie Ho and Partner Chang Man Phing contributed to the latest edition of Lexology In-Depth: Life Sciences Law 2024, sharing their expertise on Singapore's regulatory framework governing the life sciences sector.
In the chapter, they provide an in-depth overview of the regulatory landscape in Singapore, covering pharmaceuticals, biotechnology, and medical devices. They highlight the roles of key regulatory bodies, including the Health Sciences Authority (HSA) and the Ministry of Health (MOH), and address essential topics including licensing, clinical trials, marketing authorisation, and post-approval controls.
Click below to read the full chapter.